NeoPharm Suspends Glioblastoma Trials Following Disappointing Phase III Results

Firm seeks meeting with FDA to determine path forward.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet